Proscia

“Concentriq Embeddings not only accelerates AI development but will spark a new wave of innovation in pathology. It empowers teams to achieve breakthroughs faster and at a scale we’ve never imagined before, setting the stage for transformative advancements in both research and patient care.” - Our VP of AI Research & Development, Julianna Ianni Read more on how our recent launch will advance AI development in Drug Target Review. https://lnkd.in/eUT5zskh

AI in pathology shouldn’t just solve a single problem. It should also empower pathologists by delivering results from multiple AI applications when and where they are needed, all on a single, intuitive platform. Our Chief Strategy Officer Nathan Buchbinder unpacks this pathologist-centric approach to AI in this piece from Today's Clinical Lab: bit.ly/47IZga3

AI model development in life sciences spans numerous applications across the R&D value chain, and foundation model performance can vary across each. One of the key advantages of Concentriq Embeddings is the flexibility to leverage a variety of foundation models to find the best fit for specific use cases. Check out a few of the diverse applications that Concentriq Embeddings enables below, and see our site page to learn more: bit.ly/3zRrt1S

Our team is getting ready to head to Las Vegas for this year’s College of American Pathologists (CAP) meeting, and we'd love to meet you while we’re there. Stop by booth 405 to get a hands-on demo of the Concentriq enterprise pathology platform that immerses pathologists in an intuitive experience for viewing, interpreting, managing, and sharing whole slide images. Book a meeting here: bit.ly/3BIDsPI

Harnessing the power of foundation models is key to driving AI breakthroughs in pathology and precision medicine. However, operational challenges—like manual data transfers, external processing, and image format standardization—have often slowed progress. Until now. Concentriq Embeddings changes the game by providing a seamless way for data scientists to generate embeddings from whole slide images (WSIs) using state-of-the-art, widely trusted pathology and vision foundation models—all within the Concentriq platform, right where their data lives. This fully integrated solution dramatically accelerates the AI development process. How do we know? The performance and scalability of Concentriq Embeddings were proven in pilot programs with a top CRO, a leading pharmaceutical company, and Proscia's own AI R&D team, as shown in a recent case study. 📊 Highlights from the study: ▫️ Concentriq Embeddings enabled 𝟭𝟯𝘅 𝗳𝗮𝘀𝘁𝗲𝗿 𝗺𝗼𝗱𝗲𝗹 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 compared to traditional methods for leveraging foundation models. ▫️ Effortless scaling in the cloud allowed 𝟴𝟬 𝗺𝗼𝗱𝗲𝗹𝘀 𝘁𝗼 𝗯𝗲 𝘁𝗿𝗮𝗶𝗻𝗲𝗱 𝗶𝗻 𝘂𝗻𝗱𝗲𝗿 𝟮𝟰 𝗵𝗼𝘂𝗿𝘀 using a consumer-grade laptop. ▫️ Projected 𝗲𝗳𝗳𝗶𝗰𝗶𝗲𝗻𝗰𝘆 𝗴𝗮𝗶𝗻𝘀 𝗼𝗳 𝘂𝗽 𝘁𝗼 𝟭𝟬𝟬𝘅 with larger datasets typical in therapeutic R&D activities. Learn more about how Concentriq Embeddings is transforming AI development: bit.ly/4gXSlxN

We're excited to be featured in Fierce Biotech for the launch of Concentriq Embeddings and the Proscia AI Toolkit! See the article here: bit.ly/3XTC8RD Thank you to Conor Hale for a great piece.

Our AI portfolio now features more than 150 AI applications. That’s why we’ve revamped our site page to make it easier for you to find the information you need. You can now search our portfolio by label, stain, tissue type, and vendor. Check out our updated page featuring applications from Proscia and our partners Ibex Medical Analytics, Visiopharm, DoMore Diagnostics, Stratipath, Mindpeak GmbH, and Nucleai.  bit.ly/3Y6i0Nx

Exciting news from Proscia! 🚀 We're thrilled to announce the launch of Concentriq Embeddings and the Proscia AI Toolkit— game-changing solutions that are accelerating AI development in pathology. With Concentriq Embeddings, life sciences organizations can rapidly build AI algorithms to discover novel biomarkers, optimize clinical trials, advance companion diagnostics, and more by unlocking: ➡️𝗙𝗮𝘀𝘁𝗲𝗿 𝗔𝗜-𝗗𝗿𝗶𝘃𝗲𝗻 𝗕𝗿𝗲𝗮𝗸𝘁𝗵𝗿𝗼𝘂𝗴𝗵𝘀: Concentriq Embeddings directly connects a collection of pathology foundation models to the Concentriq platform, providing an ideal starting point for AI developers and research scientists to build robust AI algorithms that power critical drug discovery and development capabilities. ➡️𝗢𝗽𝘁𝗶𝗺𝗶𝘇𝗲𝗱 𝗔𝗜 𝗣𝗲𝗿𝗳𝗼𝗿𝗺𝗮𝗻𝗰𝗲: By leveraging a variety of foundation models, data science and AI teams can find the best fit for specific datasets and use cases, improving downstream performance while future-proofing the organization’s AI strategy as new models emerge. ➡️𝗢𝗽𝗲𝗿𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗘𝗳𝗳𝗶𝗰𝗶𝗲𝗻𝗰𝘆 𝗗𝗿𝗶𝘃𝗶𝗻𝗴 𝗔𝗜 𝗧𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻: Data science teams can eliminate the time-consuming and costly tasks typically required to manage foundation models—enabling them to focus on the complex aspects of algorithm development and deliver AI-driven innovation faster. ➡️𝗢𝗽𝗲𝗻-𝗦𝗼𝘂𝗿𝗰𝗲 𝗥𝗲𝘀𝗼𝘂𝗿𝗰𝗲𝘀 & 𝗦𝗵𝗮𝗿𝗲𝗱 𝗘𝘅𝗽𝗲𝗿𝘁𝗶𝘀𝗲: With the Proscia AI Toolkit, scientists gain access to a suite of resources that help them quickly get started with pathology foundation models and the broader use of AI on Concentriq, while benefiting from the collective insights of the digital pathology community. Read the full release: bit.ly/3zKU0pR

In our most recent survey, we asked you where you thought real-world data is having the biggest impact on life sciences R&D. Take a look at the results below.

In recognition of Pediatric Cancer Awareness Month, some of our Philly-based Proscians participated in the Parkway Run & Walk to benefit pediatric cancer research and care at the Children's Hospital of Philadelphia. It was an honor to run alongside the patients and families who inspire us daily. Thank you to the healthcare teams, scientists, and caregivers dedicated to combating childhood cancer.